RGNX
Price:
$7.8
Market Cap:
$403.24M
REGENXBIO Inc. is a biotechnology company operating in the clinical stage, dedicated to developing gene therapy candidates. These therapies are designed to introduce genes into cells, aiming either to rectify genetic deficiencies or to stimulate the body's own cells to produce therapeutic proteins or antibodies to combat diseases. Central to its therapeutic development is the proprietary NAV Technology Platform, an adeno-associated virus-based gene delivery system. The company's primary investigational asset, RGX-314, is currently in Phase III clinical trials for treating wet age-related macular degeneration. Its pipeline also includes RGX-121 and RGX-111, both in Phase I/II trials for mucop...[Read more]
Industry
Biotechnology
IPO Date
2015-09-17
Stock Exchange
NASDAQ
Ticker
RGNX
According to REGENXBIO Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.39. This represents a change of -25.72% compared to the average of -1.87 of the last 4 quarters.
The mean historical PE Ratio of REGENXBIO Inc. over the last ten years is -3.82. The current -1.39 PE Ratio has changed 3.54% with respect to the historical average. Over the past ten years (40 quarters), RGNX's PE Ratio was at its highest in in the December 2018 quarter at 87.40. The PE Ratio was at its lowest in in the June 2019 quarter at -320.40.
Average
-3.82
Median
-3.66
Minimum
-15.88
Maximum
15.37
Discovering the peaks and valleys of REGENXBIO Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 127.41%
Maximum Annual PE Ratio = 15.37
Minimum Annual Increase = -213.23%
Minimum Annual PE Ratio = -15.88
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -3.83 | 127.41% |
| 2024 | -1.68 | -43.52% |
| 2023 | -2.98 | -14.54% |
| 2022 | -3.49 | -132.12% |
| 2021 | 10.86 | -171.37% |
| 2020 | -15.22 | -4.15% |
| 2019 | -15.88 | -203.34% |
| 2018 | 15.37 | -213.23% |
| 2017 | -13.57 | 74.12% |
| 2016 | -7.79 | 16.91% |
The current PE Ratio of REGENXBIO Inc. (RGNX) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.83
5-year avg
-0.22
10-year avg
-3.82
REGENXBIO Inc.’s PE Ratio is greater than Absci Corporation (-8.93), greater than Verastem, Inc. (-1.65), greater than MoonLake Immunotherapeutics (-4.95), greater than Olema Pharmaceuticals, Inc. (-4.71), greater than 4D Molecular Therapeutics, Inc. (-3.63), greater than Ventyx Biosciences, Inc. (-9.36), greater than Prothena Corporation plc (-3.18), greater than Corvus Pharmaceuticals, Inc. (-21.65), greater than KalVista Pharmaceuticals, Inc. (-8.36), less than Gossamer Bio, Inc. (-0.21),
| Company | PE Ratio | Market cap |
|---|---|---|
| -8.93 | $1.16B | |
| -1.65 | $285.57M | |
| -4.95 | $1.41B | |
| -4.71 | $830.67M | |
| -3.63 | $504.99M | |
| -9.36 | $1.00B | |
| -3.18 | $467.51M | |
| -21.65 | $1.00B | |
| -8.36 | $1.44B | |
| -0.21 | $39.40M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like REGENXBIO Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like REGENXBIO Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is REGENXBIO Inc.'s PE Ratio?
How is the PE Ratio calculated for REGENXBIO Inc. (RGNX)?
What is the highest PE Ratio for REGENXBIO Inc. (RGNX)?
What is the 3-year average PE Ratio for REGENXBIO Inc. (RGNX)?
What is the 5-year average PE Ratio for REGENXBIO Inc. (RGNX)?
How does the current PE Ratio for REGENXBIO Inc. (RGNX) compare to its historical average?